Clinical Trials Sponsored by Institut Alfred Fournier

Total 511 results

Laboratoires IPRAD
Creapharm; Institut Alfred Fournier; Axonal-Biostatem

Active, not recruiting

Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer. (HYDRAMUC)

Vaginal Disease

France
The Alfred
Stanley Medical Research Institute

Completed

The Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot Study

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Australia
The Alfred
National Trauma Research Institute

Completed

Rest Easy: Is Bed Rest Really Necessary After Surgical Repair of an Ankle Fracture?

Ankle Injuries | Fracture

Australia
The Alfred
Stanley Medical Research Institute

Completed

A Definitive Estrogen Patch Study (ADEPT)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder(Not in Manic Phase)

Australia
The Alfred
National Institutes of Health (NIH)

Completed

Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History

HIV Infections | Hepatitis B

Australia
Bayside Health
The Alfred; Baker Heart Research Institute

Completed

Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome

Marfan Syndrome
Institut Curie
Assistance Publique - Hôpitaux de Paris; Hôpital Louis Mourier

Terminated

Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds (EMGEL)

Chronic Wounds | Local Pain

France
Bayside Health
The Alfred; Baker Heart and Diabetes Institute

Unknown

Enhancement of Brown Adipose Tissue Function Via Chronic Pharmacological Treatment

Obesity | Cardiovascular Disease | Type 2 Diabetes

Australia
Macfarlane Burnet Institute for Medical Research...
The Alfred

Completed

Eliminating Hepatitis C Transmission by Enhancing Care and Treatment Among HIV Co-infected Individuals (co-EC)

Hepatitis C | HIV

Australia
The Alfred
National Health and Medical Research Council, Australia; Stanley Medical Research...

Completed

Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia (SERM)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

Australia
The Alfred
National Health and Medical Research Council, Australia; Stanley Medical Research...

Completed

Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?

Schizoaffective Disorder | Bipolar Disorder | Mania

Australia
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Ballarat Health Services

Completed

Major Depressive Disorder - Understanding The Link Between The Brain And The Heart (MDD)

Major Depressive Disorder

Australia
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Ballarat Health Services

Withdrawn

Alleviating the Metabolic Side Effects of Antipsychotic Medications

Schizophrenia

Australia
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS); The Alfred

Unknown

Determining the Prevalence of HIV-Related Neurological Disorders in the Asia Pacific

HIV Infections | HIV Related Neurological Diseases

Australia
Baker Heart and Diabetes Institute
The Alfred; Monash Medical Centre; Servier Laboratories (Australia) Pty Ltd

Unknown

Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

Australia
Alfred Rusescu Institute for Mother and Child Care
The National Research and Development Institute for Alimentary Bioresources...

Completed

Safety and Tolerability of Oat Containing Gluten-free Diet (SafeOatDiet)

Celiac Disease

Romania
Bayside Health
National Health and Medical Research Council, Australia; The Alfred; Australian...

Completed

Potential Allergens in Wine: Double-blind Placebo-controlled Trial

Food Allergy | Anaphylaxis

Australia
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Université... and other collaborators

Terminated

Vagus Nerve Stimulation a New Approach in the Treatment of Crohn's Disease (VNS)

Crohn's Disease

France
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaborators

Completed

Safety Study of a Dendritic Cell-based Cancer Vaccine in Melanoma (GeniusVac-Mel4)

Melanoma | Effects of Immunotherapy | Tumor Vaccines

France
Muhimbili University of Health and Allied Sciences
Karolinska Institutet

Completed

Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine (PCT)

Instantaneous Clearance

Tanzania
Muhimbili University of Health and Allied Sciences
Karolinska Institutet

Completed

Improved Clinical and Microscopy Diagnosis at Primary Health Care in Tanzania

Malaria

Tanzania
Muhimbili University of Health and Allied Sciences
Karolinska Institutet

Completed

Efficacy and Safety of a Single Low-dose Primaquine for the Clearance of Gametocytes

Plasmodium Falciparum

Tanzania
Upendra Devokta Memorial National Institute of...

Completed

Susceptibility Weighted Imaging for Detection of Thrombus in Acute Ischemic Stroke.

Acute Ischemic Stroke

Nepal
University Hospital, Grenoble
Institut National de la Santé Et de la Recherche Médicale, France; Université... and other collaborators

Terminated

Magnetic Resonance Imaging Evaluation of the Tissular Oxygen Saturation in Brain (GADOXY)

Stroke | Cerebral Tumor

France
Medical Mission Institute, Germany
Catholic University of Health and Allied Sciences

Completed

Prevalence of HBV in Pregnant Women Attending Antenatal Care in Tanzania (HBVPMTCT)

Hepatitis B

Tanzania
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

Hematopoietic and Lymphoid Cell Neoplasm | Non-Neoplastic Hematologic and Lymphocytic Disorder

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Recurrent Hodgkin Lymphoma | Acute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Myelodysplastic Syndrome | Recurrent Small Lymphocytic Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm | Prolymphocytic Leukemia and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

Crohn's Allogeneic Transplant Study (CATS)

Crohn Disease

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Yeego! Healthy Eating & Gardening School-Based Randomized Controlled Trial (Yeego!)

Dietary Habits | Health Behavior | Eating Behavior

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Close Assessment and Testing for Chronic Graft Versus Host Disease, CATCH Study (CATCH)

Hematopoietic and Lymphoid Cell Neoplasm

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma

Plasma Cell Myeloma

United States
Baker Heart and Diabetes Institute
The Alfred; Peter MacCallum Cancer Centre, Australia; Menzies Institute for Medical... and other collaborators

Not yet recruiting

Risk-guided Disease managEment Plan to prevEnt CAD in Patients Treated With Previous Cancer (REDEEM-CAD)

Coronary Artery Disease
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Not yet recruiting

A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking

Cigarette Smoking-Related Carcinoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Not yet recruiting

Remotely Delivered, Culturally Tailored Weight Loss Interventions Among Latina Breast Cancer Survivors

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Not yet recruiting

²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma

Plasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Recruiting

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Recurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic Syndrome | Refractory Mixed Phenotype Acute Leukemia | Refractory Acute Leukemia... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Recruiting

Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia | Myelodysplastic Syndrome

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV

Lung Carcinoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Enrolling by invitation

Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study

Lymphoma | Breast Carcinoma | Lung Carcinoma | Colorectal Carcinoma | Prostate Carcinoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer

Recurrent Bladder Urothelial Carcinoma | Bladder Urothelial Carcinoma In Situ | Stage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8 | Superficial Bladder Urothelial Carcinoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Malignant Solid Neoplasm | Breast Carcinoma | Ovarian Carcinoma | Colon Carcinoma | Pancreatic Carcinoma | Prostate Carcinoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans

Cigarette Smoking-Related Carcinoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma

Metastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Recurrent Mantle Cell Lymphoma | Metastatic Lung Non-Small Cell Carcinoma | Refractory Chronic Lymphocytic Leukemia | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Acute Lymphoblastic Leukemia | Metastatic Triple-Negative... and other conditions

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Donor | Hematopoietic Cell Transplant Recipient | HLA-A*0201 Positive Cells Present

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma

Recurrent Adult Diffuse Large Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Recurrent Burkitt Lymphoma | Refractory Burkitt Lymphoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery

Sarcoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Terminated

Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

Myelodysplastic Syndromes | Leukemia | Graft Versus Host Disease

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant

Acute Myeloid Leukemia

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Positive Psychology Intervention to Improve Quality of Life in Stem Cell Transplant Survivors and Their Caregivers

Hematopoietic Cell Transplantation Recipient

United States

Clinical Trials Sponsored by Institut Alfred Fournier

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations